Live

Aortic
Stenosis

CARDIOLOGY SOLUTIONS

Among symptomatic patients with medically treated moderate-to-severe aortic stenosis, mortality from the onset of symptoms is approximately 25 percent at one year and 50 percent at two years.1 GE Healthcare's Cardiology Solutions help you make decisions that matter for your patients, staff and hospital.

The Patient Journey

EARLY DETECTION

Due to the high mortality rates by the time patients are symptomatic, it is important to identify patients at risk, even when they are asymptomatic. Echocardiography can identify issues or abnormalities related to Aortic Valve structure and function.

Vivid™ E95/E90/S70N
cSound™ beamforming technology for exceptional visualization quality with impressive resolution in 2D, color flow, Doppler and 4D formats.


MAC™ resting ECG carts with 12SL™ Analysis
Decision support and predictive outcomes plus improved sensitivity through gender specific interpretation.


DIAGNOSIS

Diagnosis involves assessment of valve morphology, amount of stenosis or insufficiency, LV function, LV hypertrophy, and severity of symptoms. For patients with Aortic Stenosis, there are surgical and catheterization treatment options in addition to medical or palliative care. A risk calculator is typically used to quantify the risk and make a treatment decision.

SIGNA™ Works CV Imaging & Analysis Tools
A free breathing, cardiac MR to assess cardiac morphology, function, flow, tissue viability and coronary anatomy without ionizing radiation.

Vivid™ E95
Semi-automated quantification tools.

PRE-PROCEDURE PLANNING

For patients choosing a transcatheter replacement, non-invasive cardiovascular imaging, such as Ultrasound, CT, and MR are typically used to assess anatomy to plan the access site and size the valve.

Vivid™ E95 4D Auto AVQ™
Automatically segments, aligns and quantifies the aortic outflow tract - vital to device sizing and orientation for TAVI/TAVR procedures.

Revolution™ CT & CardioGraphe3
Achieve one-beat, whole heart acquisition for imaging or comprehensive cardiac assessment with or without beta blockers at any heart rate.4.

SIGNA™ Works CV Imaging & Analysis Tools
A non invasive cardiac MR to assess cardiac morphology, function, flow, tissue viability and coronary anatomy without ionizing radiation.

AW TAVI Analysis
Integrated cardiology application for sizing, planning and visualization.

INTERVENTION

During the transcatheter aortic valve replacement, steps are taken to ensure the most effective result, including valve sizing, position, and function are optimal.

Discovery™ IGS 7 OR
High-quality imaging and work-place freedom for the Hybrid OR.


Valve ASSIST 2
Interventional imaging software to plan, guide and assess valve placement.


CARESCAPE™ Monitoring Portfolio
Diagnostic quality of 12SL™ analysis and initial interpretation, along with two-way integration to the MUSE™ cardiology information system for fast, validated access to patient's 12SL history & serial comparison.


Vivid™ E95. CT Fusion
Simultaneously navigate 4D ultrasound and CT data, which can be used to relate 4D ultrasound images to X-ray fluoroscopy orientation.


PATIENT FOLLOW-UP

After the procedure, care is taken to ensure functionality of the valve typically using non-invasive imaging and ECG.

Vivid™ E95/E90. Automated Function Imaging (AFI) 2.0
With the help of the artificial intelligence-based View Recognition feature, provides automated quantification of left ventricular segmental and global longitudinal strain as well as several other related parameters, including ejection fraction.


MAC™ resting ECG carts with 12SL™ Analysis
Decision support and predictive outcomes plus improved sensitivity through gender specific interpretation.


SIGNA™ Works CV Imaging & Analysis Tools
A non invasive cardiac MR to assess cardiac morphology, function, flow, tissue viability and coronary anatomy without ionizing radiation.


Revolution™ CT & CardioGraphe3
Achieve one-beat, whole heart acquisition for imaging or comprehensive cardiac assessment with or without beta blockers at any heart rate.4


DIGITAL FOUNDATION AND INNOVATIONS

Digital solutions, analytics and AI innovations such as GE Healthcare's Edison Platform, Muse and Centricity Cardio Enterprise connect our wing-to-wing technologies to practitioners for better cardiology outcomes, more efficiently.

MUSE™ ECG Management
By integrating with MUSE, data from home-based patients will be made available to clinicians on the same clinical workspace they use every day.


Centricity™ Cardio Enterprise2
Helps bridge the gaps between cardiovascular service lines with a single point of access.


REFERENCES
1. https://emedicine.medscape.com/article/150638-overview
2. Centricity Cardio Enterprise is comprised of Centricity Universal Viewer and Centricity Cardio WorkflowGE World Class Cardiac CT PPTX, 2017, slide 26 and https://www.gehealthcare.com/products/computed-tomography/revolution-family/revolution-ct, Smart Cardiac section.
3. Cardiographe is the only dedicated cardiology CT on the market.
4. GE World Class Cardiac CT PPTX, 2017, slide 26 and https://www.gehealthcare.com/products/computed-tomography/revolution-family/revolution-ct, Smart Cardiac section.
5. Valve ASSIST 2 is a commercial package which includes TAVI Analysis + HeartVision 2 and requires AW workstation with Volume Viewer, Volume Viewer Interventional. These applications are sold separately.